NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
The aims of this investigation are to
- assess the benefit of contraception with copper intra-uterine devices (IUDs) compared to hormonal IUDs in women of childbearing age with a desire or indication for contraception with regard to patient-relevant outcomes. The focus of the assessment is on whether the 2 types of IUDs differ in terms of their positive and negative side effects.
- determine the costs (intervention costs) and assess the cost-effectiveness of contraception with copper IUDs compared to hormonal IUDs
- review ethical, social, legal, and organizational aspects associated with the medical intervention.
Keywords:
Intrauterine Devices – Medicated, Intrauterine Devices – Copper, Benefit Assessment, Systematic Review, Technology Assessment – BiomedicalContents
Publishing details
Publisher
Institute for Quality and Efficiency in Health Care (IQWiG)
Topic
Contraception: Comparison of hormonal IUD and copper IUD
HTA No.
HT21-05
Date of project start
3 September 2021
Address of publisher:
Authors
- Fülöp Scheibler, SHARE TO CARE, Patientenzentrierte Versorgung GmbH, Cologne, Germany
- Marion Danner, DARUM Marion Danner und Anne Rummer GbR, Cologne, Germany
- Anne Rummer, DARUM Marion Danner und Anne Rummer GbR, Cologne, Germany
- Karoline Weik, TAKEPART Media + Science GmbH, Cologne, Germany
- Annette Bäumer, AescuLaw Lawyers Dr. Bäumer & Viehweg, Cologne, Germany
- Katharina Wehrmann (previously Rüssel), Gynaecology and Obstetrics Hospital, Kaiserswerther Diakonie, Düsseldorf, Germany
- Björn Lampe, Gynaecology and Obstetrics Hospital, Kaiserswerther Diakonie, Düsseldorf, Germany
Reviewer
- Günter Emons, Women’s University Hospital – Translational Gynaecology, Göttingen, Deutschland
IQWiG coordinated the project and conducted the literature search for the domains “Benefit assessment“ and “Health economic evaluation” and prepared the easily understandable summary (“HTA kompakt”).
According to §139b (3) No. 2 of Social Code Book (SGB) V, Statutory Health Insurance, external experts who are involved in the Institute’s research commissions must disclose “all connections to interest groups and contract organizations, particularly in the pharmaceutical and medical devices industries, including details on the type and amount of any remuneration received”. The Institute received the completed Form for disclosure of potential conflicts of interest from each external expert. The information provided was reviewed by a Committee of the Institute specifically established to assess conflicts of interests. The information on conflicts of interest provided by the external experts and external reviewers is presented in Chapter A11 of the full report. No conflicts of interest were detected that could endanger professional independence with regard to the work on the present commission.
- 1
Translation of Chapters 1 to 9 of the HTA report HT21-05 Empfängnisverhütung: Vergleich von Hormonspirale und Kupferspirale (Version 1.0; Status: 29 March 2023 [German original], XX October 2023 [English translation]). Please note: This document was translated by an external translator and is provided as a service by IQWiG to English-language readers.
- NLM CatalogRelated NLM Catalog Entries
- ContraceptionContraception
- Allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma a...Allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma and in T-cell non-Hodgkin lymphoma
- beta-tubulin, partial [Juglanconis sp. RB-2023b]beta-tubulin, partial [Juglanconis sp. RB-2023b]gi|2647695925|gb|WRQ97252.1|Protein
- beta-tubulin, partial [Fusarium decemcellulare]beta-tubulin, partial [Fusarium decemcellulare]gi|2647695935|gb|WRQ97257.1|Protein
- ECM34 Ecm34p [Saccharomyces cerevisiae S288C]ECM34 Ecm34p [Saccharomyces cerevisiae S288C]Gene ID:856342Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...